Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Yuka Group's revenue for the
three
months ended in Sep. 2014 was $0.19 Mil.
Its revenue for the trailing twelve months (TTM) ended in Sep. 2014 was $0.51 Mil.
Yuka Group's Revenue per Share for the
three
months ended in Sep. 2014 was $0.00.
Its Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2014 was $0.00.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Yuka Group Revenue Related Terms
Yuka Group Revenue Historical Data
* Premium members only.
The historical data trend for Yuka Group's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Yuka Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yuka Group Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yuka Group's Revenue distribution charts can be found below:
* The bar in red indicates where Yuka Group's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Sep. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.51 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Yuka Group (YUKA) has a Revenue of $0.51 Mil as of Sep. 2014. Revenue is the total amount a company generates as sales through its operations. View historical data on Yuka Group and its competitors.
Is Yuka Group's Revenue too high?
Yuka Group's current Revenue is $0.51 Mil.
How does Yuka Group's Revenue compare to ESTRF and HALN?
Yuka Group's Revenue of $0.51 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Providers & Services company?
A good Revenue depends on the Healthcare Providers & Services industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Yuka Group and its competitors. Yuka Group's current Revenue is $0.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yuka Group stock overvalued right now?
Yuka Group (YUKA) has a current Revenue of $0.51 Mil. The current Revenue is $0.51 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Yuka Group (YUKA), the current Revenue is $0.51 Mil as of Sep. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Yuka Group Inc is a holding company which operates through its subsidiary. It is a health care provider that provides products and services using edge specialized medical equipment, prescription medications, supplements, peptides, stem-cells, etc. to help patients with areas of their life that traditional medical doctors who are focused on sick care do not address. These areas include but are not limited to anti-aging medicine, esthetics, weight loss, increased energy, erectile dysfunction treatments, etc.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
YUKA has been successfully added to your 
